| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.24B | -4.7% |
| Gross profit | ¥0.09B | — |
| Operating income | ¥0.05B | — |
| Net income | ¥0.04B | -15.4% |
| Gross margin | 35.6% | Net margin 15.2% |
| Revenue Q/Q | -14.7% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.15B | 64.4% |
| R&D | ¥0.00B | 1.2% |
| SG&A | ¥0.03B | 13.6% |
| Tax & other | ¥0.01B | 5.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
新开普 ・ 依米康 ・ 初灵信息 ・ 金信诺 ・ 卫宁健康 ・ 仟源医药 ・ 常山药业 ・ 星星科技 ・ 开山股份 ・ 精锻科技 ・ 新天科技 ・ 新莱应材
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies